Epidermal Growth Factor Receptor Down-Regulation Triggers Human Myoblast Differentiation

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Leroy, Marina C ^a   Perroud, Julie ^a   Darbellay, Basile ^b   Bernheim, Laurent ^a   Konig, Stephane ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; EPIDERMAL GROWTH FACTOR RECEPTOR; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; MYOCYTE ENHANCER FACTOR 2; MYOGENIN; MYOSIN HEAVY CHAIN; SMALL INTERFERING RNA; SOMATOMEDIN RECEPTOR;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; HYPERPOLARIZATION; MYOBLAST; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

CELL CYCLE CHECKPOINTS; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; MYOBLASTS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSCRIPTIONAL ACTIVATION;

EID: 84881581276     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071770     Document Type: Article

References (45)

1. Dhawan J, Rando TA, (2005) Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol 15: 666-673.
2. Konig S, Hinard V, Arnaudeau S, Holzer N, Potter G, et al. (2004) Membrane hyperpolarization triggers myogenin and myocyte enhancer factor-2 expression during human myoblast differentiation. JBiolChem 279: 28187-28196.
3. Arnaudeau S, Holzer N, Konig S, Bader CR, Bernheim L, (2006) Calcium sources used by post-natal human myoblasts during initial differentiation. JCell Physiol 208: 435-445.
4. Darbellay B, Arnaudeau S, Konig S, Jousset H, Bader C, et al. (2009) STIM1- and Orai1-dependent store-operated calcium entry regulates human myoblast differentiation. J Biol Chem 284: 5370-5380.
5. Black BL, Olson EN, (1998) Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. AnnuRevCell DevBiol 14: 167-196.
6. Molkentin JD, Olson EN, (1996) Defining the regulatory networks for muscle development. Curr Opin Genet Dev 6: 445-453.
7. Karalaki M, Fili S, Philippou A, Koutsilieris M, (2009) Muscle regeneration: cellular and molecular events. In Vivo 23: 779-796.
8. Fischer-Lougheed J, Liu JH, Espinos E, Mordasini D, Bader CR, et al. (2001) Human myoblast fusion requires expression of functional inward rectifier Kir2.1 channels. JCell Biol 153: 677-686.
9. Liu JH, Bijlenga P, Fischer-Lougheed J, Occhiodoro T, Kaelin A, et al. (1998) Role of an inward rectifier K+ current and of hyperpolarization in human myoblast fusion. JPhysiol 510 (Pt 2): 467-476.
10. Hinard V, Belin D, Konig S, Bader CR, Bernheim L, (2008) Initiation of human myoblast differentiation via dephosphorylation of Kir2.1 K+ channels at tyrosine 242. Development 135: 859-867.
11. Wells A, (1999) EGF receptor. IntJBiochemCell Biol 31: 637-643.
12. Oda K, Matsuoka Y, Funahashi A, Kitano H (2005) A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol 1: 2005 0010.
13. Normanno N, De LA, Bianco C, Strizzi L, Mancino M, et al. (2006) Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366: 2-16.
14. Hung LY, Tseng JT, Lee YC, Xia W, Wang YN, et al. (2008) Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression. Nucleic Acids Res 36: 4337-4351.
15. Grass B, Wachtel M, Behnke S, Leuschner I, Niggli FK, et al. (2009) Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2beta as biomarkers for rhabdomyosarcoma diagnostics. Histopathology 54: 873-879.
16. Wachtel M, Runge T, Leuschner I, Stegmaier S, Koscielniak E, et al. (2006) Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry. JClinOncol 24: 816-822.
17. Olwin BB, Hauschka SD, (1988) Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture. JCell Biol 107: 761-769.
18. Luetteke NC, Lee DC, Palmiter RD, Brinster RL, Sandgren EP, (1993) Regulation of fat and muscle development by transforming growth factor alpha in transgenic mice and in cultured cells. Cell Growth Differ 4: 203-213.
19. Horikawa M, Higashiyama S, Nomura S, Kitamura Y, Ishikawa M, et al. (1999) Upregulation of endogenous heparin-binding EGF-like growth factor and its role as a survival factor in skeletal myotubes. FEBS Lett 459: 100-104.
20. Baroffio A, Aubry JP, Kaelin A, Krause RM, Hamann M, et al. (1993) Purification of human muscle satellite cells by flow cytometry. Muscle Nerve 16: 498-505.
21. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR, (1997) The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. JBiolChem 272: 6653-6662.
22. Allen RE, Boxhorn LK, (1989) Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor. J Cell Physiol 138: 311-315.
23. Kleiman LB, Maiwald T, Conzelmann H, Lauffenburger DA, Sorger PK, (2011) Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding. Mol Cell 43: 723-737.
24. Liu P, Sudhaharan T, Koh RM, Hwang LC, Ahmed S, et al. (2007) Investigation of the dimerization of proteins from the epidermal growth factor receptor family by single wavelength fluorescence cross-correlation spectroscopy. Biophys J 93: 684-698.
25. Abdelmohsen K, Gerber PA, von Montfort C, Sies H, Klotz LO, (2003) Epidermal growth factor receptor is a common mediator of quinone-induced signaling leading to phosphorylation of connexin-43: role of glutathione and tyrosine phosphatases. J Biol Chem 278: 38360-38367.
26. Salomon DS, Brandt R, Ciardiello F, Normanno N, (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit RevOncolHematol 19: 183-232.
27. Schneider MR, Wolf E, (2009) The epidermal growth factor receptor ligands at a glance. J Cell Physiol 218: 460-466.
28. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, et al. (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
29. Nadal-Ginard B, (1978) Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell 15: 855-864.
30. Clegg CH, Linkhart TA, Olwin BB, Hauschka SD, (1987) Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J Cell Biol 105: 949-956.
31. Ge X, Zhang Y, Jiang H (2013) Signaling pathways mediating the effects of insulin-like growth factor-I in bovine muscle satellite cells. Mol Cell Endocrinol.
32. Leloup L, Daury L, Mazeres G, Cottin P, Brustis JJ, (2007) Involvement of the ERK/MAP kinase signalling pathway in milli-calpain activation and myogenic cell migration. Int J Biochem Cell Biol 39: 1177-1189.
33. Dorman CM, Johnson SE, (1999) Activated Raf inhibits avian myogenesis through a MAPK-dependent mechanism. Oncogene 18: 5167-5176.
34. Wu Z, Woodring PJ, Bhakta KS, Tamura K, Wen F, et al. (2000) p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol 20: 3951-3964.
35. Li J, Johnson SE, (2006) ERK2 is required for efficient terminal differentiation of skeletal myoblasts. Biochem Biophys Res Commun 345: 1425-1433.
36. Gredinger E, Gerber AN, Tamir Y, Tapscott SJ, Bengal E, (1998) Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J Biol Chem 273: 10436-10444.
37. Golding JP, Calderbank E, Partridge TA, Beauchamp JR, (2007) Skeletal muscle stem cells express anti-apoptotic ErbB receptors during activation from quiescence. ExpCell Res 313: 341-356.
38. Wischmeyer E, Doring F, Karschin A, (1998) Acute suppression of inwardly rectifying Kir2.1 channels by direct tyrosine kinase phosphorylation. JBiolChem 273: 34063-34068.
39. Sun Y, Chen M, Lowentritt BH, Van Zijl PS, Koch KR, et al. (2007) EGF and HB-EGF modulate inward potassium current in human bladder urothelial cells from normal and interstitial cystitis patients. Am J Physiol Cell Physiol 292: C106-114.
40. Gao Z, Lau CP, Wong TM, Li GR, (2004) Protein tyrosine kinase-dependent modulation of voltage-dependent potassium channels by genistein in rat cardiac ventricular myocytes. Cell Signal 16: 333-341.
41. Okamoto F, Okabe K, Kajiya H, (2001) Genistein, a soybean isoflavone, inhibits inward rectifier K(+) channels in rat osteoclasts. Jpn J Physiol 51: 501-509.
42. Chiang CE, Luk HN, Chen LL, Wang TM, Ding PY, (2002) Genistein inhibits the inward rectifying potassium current in guinea pig ventricular myocytes. J Biomed Sci 9: 321-326.
43. Zhao Z, Liu B, Zhang G, Jia Z, Jia Q, et al. (2008) Molecular basis for genistein-induced inhibition of Kir2.3 currents. Pflugers Arch 456: 413-423.
44. Zhang DY, Wu W, Deng XL, Lau CP, Li GR, (2011) Genistein and tyrphostin AG556 inhibit inwardly-rectifying Kir2.1 channels expressed in HEK 293 cells via protein tyrosine kinase inhibition. BiochimBiophysActa 1808: 1993-1999.
45. Sweeney C, Carraway KL, (2004) Negative regulation of ErbB family receptor tyrosine kinases. Br J Cancer 90: 289-293.